Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Accumulated Expenses: 2020-2025

Historic Accumulated Expenses for Caribou Biosciences (CRBU) over the last 5 years, with Sep 2025 value amounting to $19.4 million.

  • Caribou Biosciences' Accumulated Expenses fell 23.96% to $19.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.4 million, marking a year-over-year decrease of 23.96%. This contributed to the annual value of $23.6 million for FY2024, which is 11.76% up from last year.
  • According to the latest figures from Q3 2025, Caribou Biosciences' Accumulated Expenses is $19.4 million, which was down 5.74% from $20.5 million recorded in Q2 2025.
  • Caribou Biosciences' 5-year Accumulated Expenses high stood at $25.4 million for Q3 2024, and its period low was $11.2 million during Q1 2022.
  • Its 3-year average for Accumulated Expenses is $19.9 million, with a median of $19.9 million in 2025.
  • As far as peak fluctuations go, Caribou Biosciences' Accumulated Expenses skyrocketed by 51.39% in 2024, and later dropped by 23.96% in 2025.
  • Over the past 5 years, Caribou Biosciences' Accumulated Expenses (Quarterly) stood at $13.1 million in 2021, then rose by 22.40% to $16.1 million in 2022, then skyrocketed by 31.44% to $21.1 million in 2023, then climbed by 11.76% to $23.6 million in 2024, then dropped by 23.96% to $19.4 million in 2025.
  • Its last three reported values are $19.4 million in Q3 2025, $20.5 million for Q2 2025, and $19.9 million during Q1 2025.